Researchers identify key protein required for therapeutic resistance in aggressive br
Researchers at the Lady Davis Institute have identified a key protein that is required for resistance to chemotherapy in the most aggressive form of breast cancer. This holds the promise of opening the door to new therapies for overcoming drug resistance.
Threaded Mode